Inify launches UK lab to fast-track diagnoses

A new arrival to Oxfordshire’s innovation district is set to transform cancer diagnostics with the opening of a “state-of-the-art” facility.

Swedish company Inify Laboratories has chosen Milton Park as the location for its first UK base, becoming the second occupier at the award-winning Nebula development. 

The firm specialises in AI-powered digital pathology, with its custom-built laboratory designed to tackle growing demand for cancer diagnostics while supporting NHS services under increasing strain.

In Sweden, Inify already processes around 80 per cent of prostate biopsies in Stockholm and ten per cent nationwide, providing results in an average of 3.5 days compared to NHS turnaround times of two to three weeks. 

Its proprietary software, INIFY® Prostate, delivers higher than 99 per cent sensitivity and 97 per cent specificity in clinical studies, with every case reviewed by a pathologist before reporting.

Bosses say the Milton Park laboratory brings together Inify’s clinical, laboratory and commercial functions under one roof, giving the company control of the entire diagnostic process from sample logistics to AI analysis. 

They add the design of the space allows for streamlined digital workflows, boosting reporting speed, accuracy and image quality.

Kate Bucknall, managing director of Inify UK, said: “Our new base at Milton Park is a real milestone in our mission to improving cancer care and reducing delays in patient pathways. 

“Our recent success shows that digitised, AI-supported workflows can halve the time from biopsy to diagnosis, which has been transformative for both patients and clinicians in Sweden.

“With around 120,000 prostate biopsy patients requiring support every year, the UK’s demand for diagnostics is around six times larger than in Sweden. 

“In the UK, our ageing population, growing awareness and a national shortage of pathologists and biomedical scientists mean we have a significant bottleneck in prostate diagnosis. 

“We want to tackle that challenge head-on in our new facility, by giving patients answers as soon as possible, while providing quality and efficiency gains across the pathway. 

“The Inify lab will have capacity to handle a volume similar to the country’s total demand.”

Nebula, which won Best Commercial Building at the 2025 OxProp Awards, offers flexible facilities for advanced research and development and technical operations. 

Its sustainable design incorporates glulam timber beams that cut the building’s carbon footprint by 686 tonnes of CO2, alongside LED lighting, efficient climate control and EV charging.

Kate added: “After an extensive search, we chose Milton Park based on its vibrant community, strong transport links and access to exceptional talent near Oxford and London. 

“Nebula was also ideal for us to build a state-of-the-art lab from scratch. 

“The buildings’ eco-friendly credentials, timber frame and light-filled design aligns with our Scandinavian aesthetic and sustainability approach.

“The new space is welcoming, for both the Inify team and also for our clinicians and partners. 

“From wellbeing events and sense of community to transport connections, the park is somewhere we feel people will want to come to work.”

Tom Booker, commercial manager at MEPC Milton Park, added: “We’re thrilled that Inify has chosen Milton Park as its UK home. 

“The team’s decision to join the Milton Park community reinforces our position as a home for leading life science and med-tech organisations to collaborate, innovate and grow. 

“Inify’s work in Sweden is a real example of how innovation can deliver meaningful impact in healthcare. 

“We look forward to seeing the difference it can make on patient outcomes in its new UK base here at Milton Park.”

Looking to promote your product/service to SME businesses in your region? Find out how Bdaily can help →